Forigerimod

DB12490InvestigationalProtein Based Therapies

Forigerimod is under investigation for the treatment of Lupus Erythematosus, Systemic.

Code names
IPP-201101

Resolves to

Compound
UNII1JRB6UKG4QCAS497156-60-2

What you can answer from here — as of February 21, 2021

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Forigerimod, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In